Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas

Survival outcomes following multimodal treatment of operable oesophageal and gastrooesophageal cancer remain disappointingly poor. Although an appreciation of the impact of both tumour location and histological subtype is now shaping the design of clinical trials, there has been a lack of consensus...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Samantha J., O’Cathail, Sean M., Coles, Bernadette, Crosby, Tom, Mukherjee, Somnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Gastrointestinal Cancers (J Meyer, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315732/
https://www.ncbi.nlm.nih.gov/pubmed/28213876
http://dx.doi.org/10.1007/s11912-017-0559-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315732/
https://www.ncbi.nlm.nih.gov/pubmed/28213876
http://dx.doi.org/10.1007/s11912-017-0559-8

Ejemplares similares